TrialBMC cancer2006

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience.

Alessandro Passardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.